Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myocardial zonula adherens protein (MYZAP) is a protein abundantly expressed in cardiac tissue, concentrated at intercalated discs of cardiomyocytes where it is involved in cell–cell adhesion and signaling. It participates in cellular signaling through Rho-related GTP-binding proteins and activates transcription factor SRF, which is critical for maintaining cardiac structure and function. MYZAP is essential for normal cardiac performance; its dysfunction is associated with cardiac disease but it is not currently recognized as a therapeutic target, nor are there known drugs or biomarkers specific to it[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myocardial zonula adherens protein (MYZAP).